ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

NCT05198102 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of COVID-19

Interventions

BIOLOGICAL: Recombinant novel coronavirus vaccine (CHO cells)

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.